Cargando…

Plant made anti-HIV microbicides—A field of opportunity

HIV remains a significant global burden and without an effective vaccine, it is crucial to develop microbicides to halt the initial transmission of the virus. Several microbicides have been researched with various levels of success. Amongst these, the broadly neutralising antibodies and peptide lect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotter-Stark, Hester C.T., Rybicki, Edward P., Chikwamba, Rachel K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132877/
https://www.ncbi.nlm.nih.gov/pubmed/22750509
http://dx.doi.org/10.1016/j.biotechadv.2012.06.002
_version_ 1783517523085361152
author Lotter-Stark, Hester C.T.
Rybicki, Edward P.
Chikwamba, Rachel K.
author_facet Lotter-Stark, Hester C.T.
Rybicki, Edward P.
Chikwamba, Rachel K.
author_sort Lotter-Stark, Hester C.T.
collection PubMed
description HIV remains a significant global burden and without an effective vaccine, it is crucial to develop microbicides to halt the initial transmission of the virus. Several microbicides have been researched with various levels of success. Amongst these, the broadly neutralising antibodies and peptide lectins are promising in that they can immediately act on the virus and have proven efficacious in in vitro and in vivo protection studies. For the purpose of development and access by the relevant population groups, it is crucial that these microbicides be produced at low cost. For the promising protein and peptide candidate molecules, it appears that current production systems are overburdened and expensive to establish and maintain. With recent developments in vector systems for protein expression coupled with downstream protein purification technologies, plants are rapidly gaining credibility as alternative production systems. Here we evaluate the advances made in host and vector system development for plant expression as well as the progress made in expressing HIV neutralising antibodies and peptide lectins using plant-based platforms.
format Online
Article
Text
id pubmed-7132877
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71328772020-04-08 Plant made anti-HIV microbicides—A field of opportunity Lotter-Stark, Hester C.T. Rybicki, Edward P. Chikwamba, Rachel K. Biotechnol Adv Research Review Paper HIV remains a significant global burden and without an effective vaccine, it is crucial to develop microbicides to halt the initial transmission of the virus. Several microbicides have been researched with various levels of success. Amongst these, the broadly neutralising antibodies and peptide lectins are promising in that they can immediately act on the virus and have proven efficacious in in vitro and in vivo protection studies. For the purpose of development and access by the relevant population groups, it is crucial that these microbicides be produced at low cost. For the promising protein and peptide candidate molecules, it appears that current production systems are overburdened and expensive to establish and maintain. With recent developments in vector systems for protein expression coupled with downstream protein purification technologies, plants are rapidly gaining credibility as alternative production systems. Here we evaluate the advances made in host and vector system development for plant expression as well as the progress made in expressing HIV neutralising antibodies and peptide lectins using plant-based platforms. Elsevier Inc. 2012 2012-06-27 /pmc/articles/PMC7132877/ /pubmed/22750509 http://dx.doi.org/10.1016/j.biotechadv.2012.06.002 Text en Copyright © 2012 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Review Paper
Lotter-Stark, Hester C.T.
Rybicki, Edward P.
Chikwamba, Rachel K.
Plant made anti-HIV microbicides—A field of opportunity
title Plant made anti-HIV microbicides—A field of opportunity
title_full Plant made anti-HIV microbicides—A field of opportunity
title_fullStr Plant made anti-HIV microbicides—A field of opportunity
title_full_unstemmed Plant made anti-HIV microbicides—A field of opportunity
title_short Plant made anti-HIV microbicides—A field of opportunity
title_sort plant made anti-hiv microbicides—a field of opportunity
topic Research Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132877/
https://www.ncbi.nlm.nih.gov/pubmed/22750509
http://dx.doi.org/10.1016/j.biotechadv.2012.06.002
work_keys_str_mv AT lotterstarkhesterct plantmadeantihivmicrobicidesafieldofopportunity
AT rybickiedwardp plantmadeantihivmicrobicidesafieldofopportunity
AT chikwambarachelk plantmadeantihivmicrobicidesafieldofopportunity